TRIPS Agreement
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), concluded in 1994 as part of the Uruguay Round and administered by the WTO, imposed comprehensive intellectual property protections on every WTO member state. The agreement requires patent protection for at least twenty years, copyright protection for at least fifty years after the author's death, and trademark protection of indefinite duration. It was drafted largely by a coalition of American pharmaceutical, software, and entertainment companies operating through the Intellectual Property Committee, and was adopted over the objections of developing nations that correctly predicted it would raise the cost of medicines, restrict technology transfer, and constrain their policy space for decades. Chang treats TRIPS as the most consequential and damaging single instrument in the contemporary architecture of ladder-kicking — a regime that imposes on every developing nation IP protections that the United States itself did not adopt until late in its own industrialization.
The Legitimacy TRIPS Secured — Contrarian ^ Opus
There is a parallel reading that begins not from what TRIPS prohibited but from what it legitimized. Before 1995, intellectual property was a patchwork of national regimes with wildly varying enforcement and almost no binding dispute resolution. Pharmaceutical formulations were unpatentable in India. Software copyright was unclear or non-existent in much of the developing world. Technology transfer occurred, but so did wholesale appropriation with no recourse. TRIPS created, for the first time, a unified global framework with binding enforcement — a regime that, whatever its constraints, established the principle that knowledge work has value that legal systems should protect.
The consequences for knowledge workers in developing nations are more ambiguous than the entry suggests. Indian software developers, Brazilian pharmaceutical researchers, Chinese AI engineers — all operate in labor markets where their skills command value partly because TRIPS established that the outputs of knowledge work are property. The regime creates asymmetries of power, certainly, but it also creates the conditions under which knowledge work is compensated rather than simply appropriated by whoever has distribution capacity. The flexibility that nineteenth-century America enjoyed existed in a world where most knowledge work was artisanal and local; TRIPS operates in a world where knowledge work is globalized and the question is not whether it will be protected but whose protections will govern. The American pharmaceutical companies that drafted TRIPS were rent-seeking, but they were also articulating a principle — that innovation requires protection — that benefits more than just incumbents.
In the AI Story
The historical record on American IP practice during the country's industrialization is starkly at odds with the requirements TRIPS imposes globally. American copyright law explicitly excluded foreign authors until 1891, allowing American publishers to reprint British books without compensation throughout the formative period of American publishing. American patent law was substantially weaker than European patent law throughout the nineteenth century, and American firms routinely copied European technology with neither legal nor cultural opprobrium. The Singer sewing machine, the steamboat, the telegraph, the railroad — all involved substantial American copying of European originals.
The contrast with TRIPS requirements is sharp. American developmental practice required exactly the IP flexibility that TRIPS now prohibits for developing nations. The flexibility was used successfully to build American industrial capability. The same flexibility, sought by contemporary developing nations attempting to build pharmaceutical, software, or AI capability, is denied through the binding international commitments that TRIPS established.
The most visible damage from TRIPS has been in pharmaceutical access. The agreement's requirements for patent protection on medicines have produced documented increases in drug prices in developing countries, with measurable consequences for public health outcomes. The 2001 Doha Declaration on TRIPS and Public Health partially mitigated these effects by affirming flexibility for compulsory licensing in public health emergencies, but the underlying constraint remains.
The relevance to AI is direct. TRIPS-style IP protections constrain the development of alternatives to incumbent AI platforms, restrict the ability to reverse-engineer or modify proprietary models, and limit the ability of developing nations to build domestic AI capability through learning from incumbents — exactly the strategy that successful developers historically used. The IP regime that was justified as encouraging innovation has, in practice, served to lock in incumbent advantages and constrain the development paths available to followers.
Origin
TRIPS emerged from a sustained advocacy campaign by major American intellectual-property-intensive industries during the 1980s. The Intellectual Property Committee, founded in 1986 by twelve major American corporations, drove the campaign to embed IP requirements in the trade agreements that became the WTO framework. The strategy was to use trade access as leverage for IP commitments that could not be obtained through standalone IP negotiations.
The agreement was concluded as part of the Uruguay Round in 1994 and entered into force with the WTO in 1995. Developing countries were given transition periods of varying lengths to bring their IP regimes into compliance, but the substantive requirements were uniform. Subsequent amendments — particularly the 2001 Doha Declaration and the 2003 Decision on Implementation of Paragraph 6 — have created limited flexibility for public health purposes, but the core regime remains in place.
Key Ideas
Asymmetric historical practice. The IP regime imposed globally is substantially stricter than the regime the wealthy nations operated under during their own development.
Trade leverage. The use of trade access as leverage for IP commitments — embedding IP requirements in trade agreements rather than negotiating standalone IP treaties.
Pharmaceutical impact. Documented increases in drug prices and constraints on access to essential medicines in developing countries.
AI implications. Constraints on the development of alternatives to incumbent AI platforms and on the technology learning strategies that successful developers historically used.
Appears in the Orange Pill Cycle
Protection's Distributional Effects — Arbitrator ^ Opus
The substantive historical claim is fully correct (100%): the IP regime TRIPS imposes is stricter than what wealthy nations operated under during industrialization, and the pharmaceutical impact is documented. The question of whether this asymmetry is purely extractive or serves any legitimate function requires disaggregating what "protection" protects.
On pharmaceutical access, Edo's framing is largely right (80%). The price increases are real, the mortality effects are measurable, and the Doha flexibilities are insufficient. The contrarian point about legitimizing knowledge work applies weakly here because the knowledge workers benefiting are primarily in wealthy nations while the health costs fall on the global poor — a clear maldistribution. On AI development paths, the weighting shifts (60/40 in Edo's favor). TRIPS does constrain technology learning, but the alternative — a world with weak IP but dominated by platform power and network effects — might concentrate capability even more rapidly. The Chinese AI industry developed under formal TRIPS compliance but practical flexibility; the constraint was real but not determinative.
The synthetic frame that holds both views: intellectual property creates legitimate value for knowledge workers while distributing the costs and benefits asymmetrically. The TRIPS regime is extractive not because protection is inherently illegitimate but because the protections were designed by and for incumbents in wealthy nations, with insufficient weight given to access, learning, and the development needs of followers. The regime could protect knowledge work while permitting the flexibility that development requires — the fact that it does not reflects power, not principle.
Further reading
- Susan Sell, Private Power, Public Law: The Globalization of Intellectual Property Rights (Cambridge University Press, 2003).
- Peter Drahos and John Braithwaite, Information Feudalism: Who Owns the Knowledge Economy? (Earthscan, 2002).
- Ha-Joon Chang, Bad Samaritans (Bloomsbury, 2007), chapter 6.
- Madhavi Sunder, From Goods to a Good Life: Intellectual Property and Global Justice (Yale University Press, 2012).